Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bestcan
Beijing, Beijing, Chinabestcan.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Bestcan is a clinical-stage biotechnology company based in China that specializes in the development and manufacturing of recombinant vaccines. The company's primary focus is on human papillomavirus (HPV) prevention, with a robust pipeline that includes a 9-valent HPV vaccine currently in Phase 3 clinical trials. Bestcan utilizes a proprietary recombinant protein expression platform to produce high-quality virus-like particles (VLPs) for its vaccine candidates. Headquartered in Beijing, the company aims to address the high demand for affordable and effective cervical cancer prevention in the Chinese market. Bestcan's integrated approach spans from early-stage research to large-scale GMP manufacturing.
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- VaccineBiologicRecombinant protein
- Industry
- Biotech
Beyond the preview
Go deeper on Bestcan.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bestcan.